EFung Capital logo

EFung Capital

Asia, Guangdong, China, Shenzhen

Description

Shenzhen EFUNG Investment Management Enterprise is an institution that invests in professional biomedical industries.

Investor Profile

EFung Capital has backed more than 12 startups, with 5 new investments in the last 12 months alone. The firm has led 4 rounds, about 33% of its total and boasts 10 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Series Unknown, Series C rounds (top funding stages).
  • Majority of deals are located in China, United States, India.
  • Strong thematic focus on Health Care, Biotechnology, Pharmaceutical.
  • Led 3 rounds in the past year.

Stage Focus

  • Series A (50%)
  • Series Unknown (17%)
  • Series C (17%)
  • Angel (8%)
  • Series B (8%)

Country Focus

  • China (75%)
  • United States (17%)
  • India (8%)

Industry Focus

  • Health Care
  • Biotechnology
  • Pharmaceutical
  • Medical
  • Medical Device
  • Biopharma
  • Battery
  • Electric Vehicle
  • Financial Services
  • Fintech
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does EFung Capital frequently co-invest with?

Hyde Capital
North America, California, United States, Santa Monica
Co-Investments: 1
China Capital Management
Asia, Beijing, China, Beijing
Co-Investments: 1
RI
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Alteria Capital
Asia, Maharashtra, India, Mumbai
Co-Investments: 1
Avaana Capital
Asia, Maharashtra, India, Mumbai
Co-Investments: 1
V
North America, California, United States, San Mateo
Co-Investments: 2
HT Capital
Asia, Beijing, China, Beijing
Co-Investments: 2
Panacea Venture
North America, Midland, Cayman Islands, Grand Cayman
Co-Investments: 2
Tigermed
Asia, Zhejiang, China, Hangzhou
Co-Investments: 1

Which angels does EFung Capital often collaborate with?

Shared Deals: 1

What are some of recent deals done by EFung Capital?

Alioth

Shanghai, Shanghai, China

Alioth focuses on the development and application of technical products for pharmaceutical process technology.

BiopharmaBiotechnologyHealth CareMedicalPharmaceutical
Series BJan 15, 2026
Amount Raised: $14,354,616
Yuewei Medical

Beijing, Beijing, China

Yuewei Medical is a developer of cardiac surgery interventional medical devices.

Health CareMedical Device
Series BJan 12, 2026
Amount Raised: $14,336,301
ProteLight Pharmaceuticals

Jiangyin, Jiangsu, China

ProteLight Pharmaceuticals engages in the development and production of antimicrobial peptide drugs and chemical drugs.

BiotechnologyChemicalHealth CarePharmaceutical
Series DJan 4, 2026
Rigen Biotech

Minhang, Shanghai, China

Rigen Biotech focuses on the molecular diagnosis of thyroid tumors.

BiotechnologyHealth DiagnosticsMedical Device
Series BNov 28, 2025
Amount Raised: $14,133,676
Kind Pharmaceutical

Hangzhou, Zhejiang, China

Kind Pharmaceutical is a clinical-stage biopharmaceutical company that focuses on the discovery and development of anemia drugs.

BiopharmaBiotechnologyHealth CareTherapeutics
Series CNov 12, 2025
Amount Raised: $56,207,405
Pleryon Therapeutics

Shenzhen, Guangdong, China

Pleryon Therapeutics is a drug delivery platform company.

BiopharmaPharmaceutical
Series AAug 18, 2025
Tingsheng Technology

Nanjing, Jiangsu, China

Tingsheng Technology develops intra cardiac ultrasound ICE products.

Health CareMedical Device
Series BJun 25, 2025
Amount Raised: $13,943,695
QureBio

Shanghai, Shanghai, China

QureBio focuses on the research and development of innovative macromolecular biopharmaceuticals.

BiotechnologyHealth CareMedicalPharmaceutical
Series CJun 5, 2025
Amount Raised: $13,935,340
Novlead Biotech

Nanjing, Jiangsu, China

Novlead Biotech contributes to a safer and healthier human well-being through our technological innovations.

BiotechnologyHealth CareMedicalPharmaceutical
Series CApr 15, 2025
Shineyo Medical

Shanghai, Shanghai, China

Shineyo Medical is a provider of minimally invasive cardiovascular interventional treatment devices.

Health CareMedicalMedical Device
Series AApr 2, 2025

Find More Investors Like EFung Capital

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides